Takeshi Numata
Mito, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Intracranial efficacy of combined immune checkpoint inhibitors and platinum plus etoposide therapy in patients with extensive-disease small-cell lung cancer and brain metastases.
Journal: Cancer treatment and research communications
Published: February 22, 2026
Sarcopenia and the C-reactive protein-Albumin-Lymphocyte index as independent and complementary prognostic factors in resected non-small cell lung cancer.
Journal: Surgical oncology
Published: January 04, 2026
Cancer-associated thromboses in non-small cell lung cancer patients with epidermal growth factor receptor mutation.
Journal: Contemporary oncology (Poznan, Poland)
Published: June 03, 2025
Age and smoking intensity in non-small cell lung cancer patients with the anaplastic lymphoma kinase fusion gene.
Journal: Contemporary oncology (Poznan, Poland)
Published: December 20, 2024
Outcomes of Combined Atezolizumab Plus Chemotherapy in Non-small Cell Lung Cancer Patients in Clinical Practice.
Journal: Cancer diagnosis & prognosis
Published: November 11, 2024
Prognostic Factors for Patients with Small-Cell Lung Cancer Treated with Chemoimmunotherapy: A Retrospective Multicenter Study.
Journal: Current oncology (Toronto, Ont.)
Published: September 27, 2024
Investigation of age and smoking in NSCLC patients with uncommon EGFR mutations.
Journal: Tuberkuloz ve toraks
Published: June 13, 2024
Real Clinical Practice of Combined Atezolizumab Plus Chemotherapy in Patients With Small Cell Lung Cancer.
Journal: Anticancer research
Published: March 11, 2024
Patient Age and EGFR-positive Non-small Cell Lung Cancer: A Multicenter Retrospective Study.
Journal: Anticancer research
Published: January 20, 2024
Prognostic Impact of Preoperative Assessment of Muscle Mass and Strength in Surgically Resected Lung Cancer.
Journal: Anticancer research
Published: December 21, 2023
Variations in S100A8/A12 Gene Expression Are Associated with the Efficacy of Nintedanib and Acute Exacerbation Development in Idiopathic Pulmonary Fibrosis Patients.
Journal: American journal of respiratory cell and molecular biology
Published: August 01, 2023
Last Updated: 09/26/2026